Company Overview
TANGO THERAPEUTICS, INC.
TNGXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
62M
2025 FY
Net Income
-102M
2025 FY
Shares Outstanding
116M
2025 FY
EPS
-0.87USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1819133
Exchange
Nasdaq
Location
US